[ad_1]
Check out the companies making headlines in afternoon trading. Regeneron Pharmaceuticals – Shares of the biotech firm rose more than 1%, adding to Wednesday’s gains. This step has been taken after the verdict in favor of Regeneron in the West Virginia patent lawsuit against Mylan. BMO analyst Evan Segerman said the decision likely prevents Mylan from launching its biosimilar therapy Eylea until the patent expires. NeoGenomics – Shares of the oncology testing company fell 18% after a court issued a preliminary injunction barring the company from “making, using, selling, or offering for sale in the United States” its RaDaR technology. given. The company said it would appeal the injunction. Grand Canyon Education – Shares of the educational services company fell nearly 7% after the Federal Trade Commission filed a lawsuit against Grand Canyon Education accusing it of deceptive and illegal advertising and telemarketing practices. Penn Entertainment – The casino operator rose more than 6% after Vora Capital Management filed a 13D to nominate directors to Penn’s board. NetEase – The Chinese internet stock rose 3.2%. Shares have gained a bit this week after China’s top gaming regulator promised it would “further revise and improve” new guidelines aimed at targeting excessive gaming. Coherus Biosciences – The biopharma stock soared 21%, up more than 23% from Wednesday’s trading session. Coherus got a boost after the U.S. Food and Drug Administration approved its on-body injection system Udenica Onbody, which chemotherapy patients can take to prevent infection. JD.com – U.S.-traded shares of the Chinese e-commerce company rose 4% on Thursday. The gain came after Bloomberg News reported on Wednesday evening that JD.com was preparing to raise pay for its front-line employees. New York Times Co. – Shares rose 2.4% a day after the media company filed a lawsuit against Microsoft and ChatGate-maker OpenAI, accusing the tech companies of copyright infringement and using the newspaper’s intellectual property without permission to train chatbots. Accused of using. Iowans BioTherapeutics – The biotech stock rose 15.2% after falling nearly 19% on Wednesday. The selloff came after the FDA halted the company’s trial for the treatment of non-small cell lung cancer. Boeing – Stock fell 1% after the aerospace and defense company urged airlines to inspect its new 737 Max airplanes for possible loose bolts in the rudder control system, the Federal Aviation Administration said Thursday. Boeing recommended these inspections after an international operator found a bolt with a missing nut, and the company found another non-delivered aircraft with a loose nut. — CNBC’s Alex Haring, Fred Imbert and Jesse Pound contributed reporting.
